← Leaderboards
Ajit K Verma
University Of Wisconsin Madison
$7,705,981
Attributed
$7,705,981
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $915.5K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,705,981 · 3
By mechanism
R01$7,705,981 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Paul F Lambert$39,159,443
- Farrukh Afaq$1,522,181
Others in their field
Top investigators on “Skin Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Elaine Fuchs · University Of Chicago$26,726,187
- Allan Balmain · University Of California San Francisco$25,703,743
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- Larry Arthur$22,931,757
- Janet Ellen Dancey · Queen'S University At Kingston$22,425,599
Research focus
Skin NeoplasmsSignal TransductionLinkIn VivoSquamous Cell CarcinomaReportingOverexpressionProtein IsoformsTumor PromotionUltraviolet RaysGene ExpressionSkinResearch StudyProteinsProtein Kinase C EpsilonSignal Transduction PathwayMediatingCarcinogenesisCellsPhosphorylationSerineMolecular TargetPtgs2 GenePredisposition
Grant awards (27)
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$263,283
R01 · FY2015 · CA · contact PI
Novel Inhibitors of Prostate Cancer Progression$326,168
R01 · FY2014 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$255,383
R01 · FY2014 · CA · contact PI
Novel Inhibitors of Prostate Cancer Progression$316,081
R01 · FY2013 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$247,486
R01 · FY2013 · CA · contact PI
Novel Inhibitors of Prostate Cancer Progression$336,256
R01 · FY2012 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$263,283
R01 · FY2012 · CA · contact PI
Novel Inhibitors of Prostate Cancer Progression$336,256
R01 · FY2011 · CA · contact PI
Role of PKC in Tumor Promotion$316,003
R01 · FY2011 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$263,283
R01 · FY2011 · CA · contact PI
Role of PKC in Tumor Promotion$325,776
R01 · FY2010 · CA · contact PI
Novel Inhibitors of Prostate Cancer Progression$154,069
R01 · FY2010 · CA · contact PI
Role of PKC in Tumor Promotion$325,776
R01 · FY2009 · CA · contact PI
Role of PKC in Tumor Promotion$325,776
R01 · FY2008 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$254,537
R01 · FY2008 · CA · contact PI
Role of PKC in Tumor Promotion$325,776
R01 · FY2007 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$254,537
R01 · FY2007 · CA · contact PI
Role of PKC in Tumor Promotion$314,212
R01 · FY2006 · CA · contact PI
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$262,139
R01 · FY2006 · CA · contact PI
Role of PKC in Tumor Promotion$321,774
R01 · FY2005 · CA
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$268,448
R01 · FY2005 · CA
Role of PKC in Tumor Promotion$321,774
R01 · FY2004 · CA
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis$268,448
R01 · FY2004 · CA
Role of PKC in Tumor Promotion$321,774
R01 · FY2003 · CA
Role of PKC in Tumor Promotion$321,915
R01 · FY2002 · CA
PKC AND TUMOR PROMOTION$373,959
R01 · FY2000 · CA
PKC AND TUMOR PROMOTION$41,809
R01 · FY2000 · CA